Resmed Inc (RMD) receives a Buy rating from Citigroup

Anna Perez

Resmed Inc’s filing revealed that its Global General Counsel Rider Michael J unloaded Company’s shares for reported $12208.0 on Dec 01 ’25. In the deal valued at $244.16 per share,50 shares were sold. As a result of this transaction, Rider Michael J now holds 9,791 shares worth roughly $2.46 million.

Then, Sandercock Brett sold 1,000 shares, generating $244,160 in total proceeds. Upon selling the shares at $244.16, the Chief Financial Officer now owns 87,495 shares.

Before that, Sandercock Brett bought 1,000 shares. Resmed Inc shares valued at $244,160 were divested by the Officer at a price of $244.16 per share.

Citigroup initiated its Resmed Inc [RMD] rating to a Buy in a research note published on September 18, 2025; the price target was $330. A number of analysts have revised their coverage, including CLSA’s analysts, who increased its forecast for the stock in early September from “a Hold” to “an Outperform”. RBC Capital Mkts also remained covering RMD and has increased its forecast on July 15, 2025 with a “an Outperform” recommendation from previously “Sector perform” rating. Morgan Stanley started covering the stock on March 19, 2025. It rated RMD as “an Overweight”.

Price Performance Review of RMD

On Tuesday, Resmed Inc [NYSE:RMD] saw its stock jump 0.99% to $250.85. Over the last five days, the stock has gained 0.13%. Resmed Inc shares have risen nearly 0.61% since the year began. Nevertheless, the stocks have risen 9.69% over the past one year. While a 52-week high of $293.81 was reached on 08/22/25, a 52-week low of $199.92 was recorded on 04/07/25.

Levels Of Support And Resistance For RMD Stock

The 24-hour chart illustrates a support level at 248.79, which if violated will result in even more drops to 246.72. On the upside, there is a resistance level at 252.88. A further resistance level may holdings at 254.90.

How much short interest is there in Resmed Inc?

A steep rise in short interest was recorded in Resmed Inc stocks on 2025-11-14, growing by 1.68 million shares to a total of 10.65 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-15 was 8.96 million shares. There was a rise of 15.81%, which implies that there is a positive sentiment for the stock.

The most recent change occurred on March 19, 2025 when Morgan Stanley began covering the stock and recommended ‘”an Overweight”‘ rating.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.